Form 4: Major Shareholder Sells Over 5 Million Shares of Yubo International Biotech Stock

Boao Biotech Ltd, a significant shareholder and director of Yubo International Biotech Ltd, has sold over 5 million shares of Class A Common Stock for $0.30 per share.

Summary

• Boao Biotech Ltd, identified as a Director and 10% Owner of Yubo International Biotech Ltd (YBGJ), executed multiple sales of Class A Common Stock.
• On January 25, 2024, Boao Biotech Ltd disposed of a total of 5,040,140 shares of Class A Common Stock across nine separate transactions.
• All shares were sold at a price of $0.30 per share.
• Following these transactions, Boao Biotech Ltd's direct beneficial ownership in Yubo International Biotech Ltd stands at 19,927,660 shares of Class A Common Stock.
• Mr. Yulin Cao, the sole Director of Boao Biotech Ltd, is deemed to have voting and investment power over these shares but disclaims beneficial ownership for Section 16 purposes, except for his indirect pecuniary interest.

Sentiment

Score: 3

Explanation: The sentiment is negative due to a significant insider sale by a major shareholder and director. While the transaction itself is a factual report, large insider selling often signals a lack of confidence or a belief that the stock is fully valued, which can be a bearish indicator for investors.

Negatives

• A significant insider sale of 5,040,140 shares by a 10% owner and director, Boao Biotech Ltd, indicates a reduction in their stake.
• The sale price of $0.30 per share suggests the insider is willing to sell at this valuation, which could be perceived negatively by the market.

Risks

• Significant insider selling by a major shareholder and director can signal a lack of confidence in the company's future prospects or current valuation.
• Such large-scale selling could put downward pressure on the stock price due to increased supply in the market.
• Investor sentiment may be negatively impacted, leading to a potential decrease in demand for the company's shares.

Future Outlook

The document does not provide any forward-looking statements or guidance regarding the company's future performance or strategic direction.

Management Comments

• Mr. Yulin Cao, as the sole Director of Boao Biotech Ltd, may be deemed to have voting and investment power over the shares held by Boao Biotech Ltd.
• Mr. Yulin Cao disclaims beneficial ownership of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, except to the extent of his indirect pecuniary interest therein.

Industry Context

This Form 4 filing reports an insider transaction and does not provide broader industry context or trends. It is specific to the ownership changes within Yubo International Biotech Ltd.

Related Party Transactions

• Boao Biotech Ltd, the reporting person, is a Director and 10% Owner of Yubo International Biotech Ltd.
• Mr. Yulin Cao is the sole Director of Boao Biotech Ltd and is deemed to have indirect voting and investment power over the shares held by Boao Biotech Ltd.

Stakeholder Impact

• Shareholders may interpret the significant insider selling as a negative signal, potentially leading to decreased investor confidence and downward pressure on the stock price.
• The reduction in a major shareholder's stake could alter the ownership structure and influence dynamics within the company.

Key Dates

Recommendation

Keywords

Yubo International Biotech, YBGJ, Boao Biotech, Insider Selling, Form 4, SEC Filing, Stock Sale, Beneficial Ownership, Director, 10% Owner, Class A Common Stock